Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Povidone-iodine for VAP prevention in head trauma
NCT00950027Phase 3Terminated
- Sponsor
- CHU Rennes
- Start
- Apr 2008
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ventilator-associated pneumonia (VAP) comparing povidone iodine with placebo (2 arms). Primary endpoint: Rate of ventilator associated pneumonia at 30 days. Started Apr 2008; status: terminated.
02
Drugs
povidone-iodine
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT00950027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00950027.